Even with two diagnosed bleeding disorders, columnist Jennifer Lynne still hesitates to identify a bleed due to years of medical dismissal.

Adults with hemophilia who switched from standard to extended half-life replacement treatment products had fewer bleeding episodes.

Columnist Joe MacDonald was happy to see his son solving a problem without any prompting — a sign that he's ready to live ...

It was eye-opening for columnist G Shellye Horowitz to learn the correlation between obesity, joint pain, and bleeds.

Advanced liver organoids were able to secrete functional FVIII that could be used to stop bleeding in mice with hemophilia A, ...

The first hemophilia B patient in Germany received gene therapy Hemgenix, covered by public healthcare with efficacy-tied ...

Helping people brings me joy. As a hospice chaplain assisting families through their darkest hours, I am truly fulfilled. Outside of my work, my heart is full when I can make dinner, pick up groceries ...

Hemlibra safely reduces bleeding episodes in people with hemophilia A without inhibitors, per a review study that confirmed ...

Columnists G Shellye Horowitz, caught up in an art project, forgot that she was living with hemophilia and needed treatment.

When medical professionals aren't trained on bleeding disorders, patients face critical delays in treatment, says columnist.

Columnist Jennifer Lynne reflects on a women's retreat, where shared stories revealed gaps in medical care and the need for community.

Hemophilia is a rare disorder with three main types, each with symptoms of easy and prolonged bleeding, caused by a lack of clotting factors.